Kenvue stock drops 10% on RFK Jr. Tylenol autism report

Concerns Over Tylenol’s Safety During Pregnancy Spark Debate

A recent report has sparked concerns that the use of Tylenol, a widely used pain reliever, during pregnancy may be linked to autism. The report, which is expected to be released by the Department of Health and Human Services (HHS) this month, has led to a decline in shares of Kenvue Inc., the manufacturer of Tylenol. The HHS Secretary, Robert F. Kennedy Jr., has been vocal about his concerns over the rising rates of autism in the US and has pledged to investigate the potential causes.

The potential link between Tylenol and autism is not new, with some previous studies suggesting that the drug may pose risks to fetal development. However, other research has found no association between the use of acetaminophen, the generic name for Tylenol, and autism. The FDA and leading medical organizations, such as the American College of Obstetricians and Gynecologists, have maintained that acetaminophen is safe during pregnancy when taken as directed and after consulting a healthcare provider.

What Does the Science Say?

Despite the concerns, the scientific evidence on the link between Tylenol and autism is not conclusive. Some studies have suggested that the use of acetaminophen during pregnancy may increase the risk of autism, while others have found no association. The FDA has stated that it has not found “clear evidence” that the use of acetaminophen during pregnancy causes adverse pregnancy, birth, neurobehavioral, or developmental outcomes. However, the agency advises pregnant women to speak with their healthcare providers before using over-the-counter drugs.

The controversy surrounding Tylenol’s safety during pregnancy has led to lawsuits, with some parents claiming that they gave birth to children with autism after using the drug. However, a federal judge in Manhattan ruled in 2023 that some of these lawsuits lacked scientific evidence and later ended the litigation in 2024. The debate highlights the need for further research into the potential causes of autism and the importance of relying on scientific evidence when making decisions about healthcare.

Implications for Pregnant Women and Healthcare Providers

The potential link between Tylenol and autism has significant implications for pregnant women and healthcare providers. Pregnant women who are concerned about the safety of Tylenol should consult their healthcare providers before using the drug. Healthcare providers should also be aware of the potential risks and benefits of acetaminophen during pregnancy and provide guidance to their patients accordingly. Ultimately, the decision to use Tylenol during pregnancy should be based on a careful evaluation of the available evidence and individual circumstances.

The HHS report, which is expected to be released this month, may provide further guidance on the potential link between Tylenol and autism. However, until the report is released, it is essential to rely on scientific evidence and avoid speculation. The debate surrounding Tylenol’s safety during pregnancy highlights the importance of ongoing research and the need for clear and accurate information to inform healthcare decisions.